Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update

Honglei Ren, Ranran Han, Xuemei Chen, Xi Liu, Jieru Wan, Limin Wang, Xiuli Yang, Jian Wang

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Intracerebral hemorrhage (ICH) is a subtype of stroke with high mortality and disability but no specific or effective treatment. In the last two decades, much has been learned about the pathologic mechanisms of ICH. It is now known that after ICH onset, immune and inflammatory responses contribute to blood–brain barrier disruption, edema development, and cell death processes, jointly resulting in secondary brain injury. However, the translation of potential therapies from preclinical to clinical success has been disappointing. With the development of new laboratory technology, recent progress has been made in the understanding of ICH pathomechanisms, and promising therapeutic targets have been identified. This review provides an update of recent progress on ICH and describes the prospects for further preclinical studies in this field. Our goal is to discuss new therapeutic targets and directions for the treatment of ICH and promote the effective transformation from preclinical to clinical trials.

Original languageEnglish (US)
Pages (from-to)1752-1768
Number of pages17
JournalJournal of Cerebral Blood Flow and Metabolism
Issue number9
StatePublished - Sep 1 2020


  • Intracerebral hemorrhage
  • immune interventions
  • inflammation
  • microglia
  • secondary injury

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update'. Together they form a unique fingerprint.

Cite this